Published on 4 May 2024 on GuruFocus.com via Yahoo Finance
On May 1, 2024, Director William Hoffman sold 38,549 shares of Inari Medical Inc (NASDAQ:NARI) as reported in a recent SEC Filing. The transaction occurred with the stock priced at $42 per share, valuing the sale at approximately $1,619,058.
Warning! GuruFocus has detected 4 Warning Signs with NARI.
Inari Medical Inc specializes in the development, manufacture, and marketing of devices for the treatment of venous diseases. The company's innovative products aim to provide minimally invasive solutions to patients suffering from venous disorders.